Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

COMPASS Pathways Plc - American Depository Shares (NQ:CMPS)

3.645 +0.005 (+0.14%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 6, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 565
Open 3.645
Bid (Size) 3.580 (20)
Ask (Size) 3.970 (1)
Prev. Close 3.640
Today's Range 3.645 - 3.645
52wk Range 2.490 - 9.630
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Compass Pathways Establishes Strategic Collaboration with HealthPort to Inform the Potential Delivery of COMP360 Synthesized Psilocybin Treatment in Underserved Communities
From Compass Pathfinder Limited
Via Business Wire
Compass Pathways to Announce First Quarter Financial Results on May 8, 2025
From Compass Pathfinder Limited
Via Business Wire

Performance

YTD
-12.2%
-12.2%
1 Month
+35.0%
+35.0%
3 Month
-22.9%
-22.9%
6 Month
-19.4%
-19.4%
1 Year
-57.7%
-57.7%

More News

Read More
Why Compass Pathways Stock Was a Double-Digit Winner This Week
Via The Motley Fool
Earnings Scheduled For February 27, 2025
Via Benzinga
Compass Pathways Announces Dosing Complete for All Participants in Part A of Phase 3 COMP005 Trial of COMP360 Psilocybin for Treatment-Resistant Depression
From Compass Pathways plc
Via Business Wire
Compass Pathways Announces Completion of Recruitment for the Phase 3 COMP005 Trial of COMP360 Psilocybin for Treatment-Resistant Depression
From Compass Pathways plc
Via Business Wire
More People are Microdosing Psychedelics to Ease the Challenges of Parenting
Via Investor Brand Network
Compass Pathways Announces Publication of Results from COMP004 Study on COMP360 Psilocybin for Treatment-Resistant Depression
From Compass Pathways plc
Via Business Wire
Compass Pathways to Participate in Stifel Virtual CNS Forum
From Compass Pathways plc
Via Business Wire
US Embassy Tells Americans to Desist from Using Ayahuasca in Peru
Via Investor Brand Network
Topics Law Enforcement
Exposures Legal
Mind Medicine's Net Losses Swell In Q4, But Retail Finds At Least 3 Reasons To Stay Bullish
Via Stocktwits
Psychedelics-Focused Compass Pathways Has Established Itself As 'Credible CNS Biotechnology Company,' Analyst Says
Via Benzinga
Compass Pathways Plc (CMPS) Q4 2024 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Exposures Financial
This Plumas Bancorp Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Thursday
Via Benzinga
Compass Pathways Announces Fourth Quarter and Full-Year 2024 Financial Results and Business Highlights
From Compass Pathways plc
Via Business Wire
Compass Pathways to Participate in TD Cowen 45th Annual Health Care Conference
From Compass Pathways plc
Via Business Wire
Washington State Bills Seek to Legalize Psychedelics for Therapeutic Use
Via Investor Brand Network
Compass Pathways to announce fourth quarter and year-end financial results on February 27th, 2025
From Compass Pathways plc
Via Business Wire
Mind Medicine Getting An 'RFK Bump'? Retail Gets More Bullish As Stock Heads For Best Day In Over 10 Months
Via Stocktwits
RFK Jr. Confirmation Looms. How Kennedy Could 'Go Wild' On Health Care.
Via Investor's Business Daily
Compass Pathways to Participate in Oppenheimer 35th Annual Healthcare Life Sciences Conference
From Compass Pathways plc
Via Business Wire
Compass Pathways Appoints Steve Levine, M.D., as Chief Patient Officer
From Compass Pathways plc
Via Business Wire
Compass Pathways Announces Pricing of Underwritten Offering
From Compass Pathways plc
Via Business Wire
Compass Pathways to Be Added to the NASDAQ Biotechnology Index (NBI)
From Compass Pathways plc
Via Business Wire
Is Your Mind Ready to Consider Investing in Psychedelics Stocks?
Via The Motley Fool

Frequently Asked Questions

Is COMPASS Pathways Plc - American Depository Shares publicly traded?
Yes, COMPASS Pathways Plc - American Depository Shares is publicly traded.
What exchange does COMPASS Pathways Plc - American Depository Shares trade on?
COMPASS Pathways Plc - American Depository Shares trades on the Nasdaq Stock Market
What is the ticker symbol for COMPASS Pathways Plc - American Depository Shares?
The ticker symbol for COMPASS Pathways Plc - American Depository Shares is CMPS on the Nasdaq Stock Market
What is the current price of COMPASS Pathways Plc - American Depository Shares?
The current price of COMPASS Pathways Plc - American Depository Shares is 3.645
When was COMPASS Pathways Plc - American Depository Shares last traded?
The last trade of COMPASS Pathways Plc - American Depository Shares was at 05/06/25 04:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.